Within minutes of listing, the scrip touched a high of Rs 47.20 and over 67.95 lakh shares exchanged hands on the BSE.
Bafna Pharmaceuticals was trading at Rs 45.45 on the BSE at 10.18 am.
The company got listed with 1,59,81,335 equity shares of Rs 10 each at an issue price of Rs 40 per share.
Bafna has a manufacturing facility at Chennai and has acquired 2.65 acres of factory land in Grantylon Village, near Chennai to expand its operations to regulated market such as US and UK and also to manufacture its own products.
The company plans to utilise the proceeds of the issue towards brand building exercise in the domestic market, strengthening its research and development facility.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app